Anti-doping news

PUBLIC DISCLOSURE

The IWF reports that sample of Ms. Yue Zhou (CHN) has returned an Adverse Analytical Finding for (S1.1 Anabolic Agents) methyltestosterone. As a consequence, the athlete is provisionally suspended in view of a potential anti-doping rule violation. In any case where it is determined that the athlete did not commit an anti-doping rule violation, the relevant decision will also be

Successful IWF Anti-Doping Seminar in Pyongyang

Dr. Patrick Schamasch, Anti-Doping Commission Chairman paid a visit to Pyongyang, capital city of North Korea to hold an IWF Education Seminar. In presence of 40 attendees, coaches, doctors and officials, the Anti-Doping seminar took place on 22nd of September at the Sport Village. The comprehensive presentation covered all areas of the IWF’s robust anti-doping fight with special attention to nutritional supplements and the specificities of the new Anti-Doping Policy. Due to the entourage registration and complex result management procedures, the IWF’s Anti-Doping fight is stronger than ever. A question and answer session concluded the two hours lecture, and Dr. Schamasch was happy to give broader views about questions of common interest like roles and responsibilities as well as rights. This was the second Seminar held in North Korea in the past period, and prevention a main point of focus while the ADC gives special attention to the education of the

PUBLIC DISCLOSURE

The IWF reports that sample of Ms. Faina Sivanbayeva (KAZ) has returned an Adverse Analytical Finding for (S1.1 Anabolic Agents) dehydrochloromethyltestosterone. As a consequence, the athlete is provisionally suspended in view of a potential anti-doping rule violation. In any case where it is determined that the athlete did not commit an anti-doping rule violation, the relevant decision will also be

WARNING

On 16 September 2015, the World Anti-Doping Agency’s Executive Committee approved the 2016 List of Prohibited Substances and Methods, which will come into force on 1 January 2016. You may find the new list here The IWF Anti-Doping Commission would like to specifically call everyone’s attention to a new prohibited substance called MILDRONATE (Meldonium) which was in the WADA Monitoring Program in 2015 and will be prohibited from the 1st January 2016. The most used trade names for the substance are: mildronate, meldonium, Quaterin, Kvaretin, THP. Please note that this is not an exhaustive list. There may be other medications, supplements which could contain mildronate (labelled or not labelled). According to recent scientific publications of the WADA accredited laboratories Cologne and Moscow, 2-17 % of doping control samples collected in 2014 and 2015 contained mildronate. The IWF ADC strongly advise everyone to carefully review the new list and comply

IOC releases Anti-Doping Rules for Rio de Janeiro 2016

The International Olympic Committee (IOC) has released its Anti-Doping Rules applicable to the 2016 Games in Rio de Janeiro (Rio). All athletes competing in Rio will be subject to testing as outlined in the Anti-Doping Rules, which have been drafted in accordance with the World Anti-Doping Code and the List of Prohibited Substances and Methods. The Rules will cover the period from the opening of the Olympic Village on 24 July 2016, until the day of the closing ceremony, 21 August 2016. During this period all athletes will be subject to doping controls initiated by the IOC at any time or place, with no advance notice required to be given. The IOC Anti-Doping Rules for the Games of the XXXI Olympiad in Rio de Janeiro can be found on WADA’s website as well as on the IOC website. Source WADA,

ADAMS Maintenance – Wednesday 2 September 2015

Dear ADAMS users, WADA is planning a technical maintenance task for the ADAMS Production environment. This task is scheduled for Wednesday, September 2 2015, between 18:00 and 20:00 GMT. Therefore kindly note that the Production system (including the SMS and Mobile services) will be unavailable during this period. Should this give any concern for you, please inform WADA at [email protected]. Thank you for your understanding and cooperation, Your ADAMS